Key Takeaways
- • Global private equity exits increased 5.4% year-over-year to 3,149 deals in 2025, but deal value fell 21.2% to $312.1 billion, reflecting forced monetization at lower valuations across an aging portfolio base.
- • Average hold periods have extended to approximately seven years, up from the historical 5-6 year average (2010-2021), creating a structural backlog of approximately $3.2 trillion in assets awaiting exit strategies.
- • PE fundraising declined 11% in 2025 to $490.81 billion—the second consecutive annual slowdown—as limited partners reduced capital commitments due to delayed cash distributions and lower returns from portfolio exits.
- • Valuation gaps created post-2022 (when the S&P 500 fell 19% amid rising rates) remain unresolved, as PE firms resisted marking down portfolio company values while buyer demand remained suppressed, creating a pricing disconnect that persists into 2026.
- • The delayed exit environment has created a secondary effect: PE firms have reduced new capital deployment, moderating deal origination activity across the alternative investment landscape.
Summary
Private equity is finally adjusting to market reality after years of delayed exits and inflated portfolio valuations, though the adjustment is occurring on unfavorable terms. According to S&P Global Market Intelligence, global PE exits rose 5.4% in 2025 to 3,149 transactions, yet the total deal value declined 21.2% year-over-year to $312.1 billion. The divergence between volume and value underscores an industry under acute pressure to monetize aging assets at prices well below historical expectations.
The root cause traces to 2022, when the S&P 500 fell 19% amid aggressive rate increases. Rather than immediately mark down portfolio valuations, many PE firms maintained inflated carrying values, creating a substantial gap between what sellers believed their companies were worth and what potential acquirers and IPO investors were willing to pay. This valuation disconnect, documented by the Center for Economic and Policy Research, has proven difficult to resolve and continues to constrain exit velocity in 2026.
The structural impact is evident in hold period elongation: average portfolio company hold times now hover around seven years, up from the 5-6 year average that prevailed from 2010 through 2021. This extension has created a significant backlog, with approximately $3.2 trillion in PE-controlled assets currently awaiting exit strategies. The extended holding periods have cascading effects for limited partners (LPs), who have experienced materially delayed cash distributions. This dynamic has directly suppressed LP appetite for new capital commitments, contributing to an 11% decline in PE fundraising in 2025 to $490.81 billion—marking the second consecutive year of fundraising contraction.
The slowdown in available capital has created a secondary drag: PE firms have become more cautious about deploying capital into new acquisitions, moderating deal flow at a time when exit backlogs remain elevated. The industry remains caught between the pressure to liquidate aging portfolio positions and the challenge of obtaining acceptable valuations in a still-constrained exit market. Medline's December 2025 IPO represents a rare bright spot, but such successful exits remain exceptions rather than the norm in the current environment.
The root cause traces to 2022, when the S&P 500 fell 19% amid aggressive rate increases. Rather than immediately mark down portfolio valuations, many PE firms maintained inflated carrying values, creating a substantial gap between what sellers believed their companies were worth and what potential acquirers and IPO investors were willing to pay. This valuation disconnect, documented by the Center for Economic and Policy Research, has proven difficult to resolve and continues to constrain exit velocity in 2026.
The structural impact is evident in hold period elongation: average portfolio company hold times now hover around seven years, up from the 5-6 year average that prevailed from 2010 through 2021. This extension has created a significant backlog, with approximately $3.2 trillion in PE-controlled assets currently awaiting exit strategies. The extended holding periods have cascading effects for limited partners (LPs), who have experienced materially delayed cash distributions. This dynamic has directly suppressed LP appetite for new capital commitments, contributing to an 11% decline in PE fundraising in 2025 to $490.81 billion—marking the second consecutive year of fundraising contraction.
The slowdown in available capital has created a secondary drag: PE firms have become more cautious about deploying capital into new acquisitions, moderating deal flow at a time when exit backlogs remain elevated. The industry remains caught between the pressure to liquidate aging portfolio positions and the challenge of obtaining acceptable valuations in a still-constrained exit market. Medline's December 2025 IPO represents a rare bright spot, but such successful exits remain exceptions rather than the norm in the current environment.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.